In Memoriam: Gregory B. Root
National Coverage Determination
Back to NCD List
Tumor Antigen by Immunoassay CA 15-3/CA 27.29
CMS Policy Number: 190.29
Description: Immunoassay determinations of the serum levels of certain proteins or carbohydrates serve as tumor markers. When elevated, serum concentration of markers may reflect tumor size & grade. This policy specifically addresses the following tumor antigens: CA 15-3 and CA 27.29
Multiple tumor markers are available for monitoring the response of certain malignancies to therapy and assessing whether a residual tumor exists post-surgical therapy. CA 15-3 is often medically necessary to aid in the management of patients with breast cancer. Serial testing must be used in conjunction with other clinical methods for monitoring breast cancer. For monitoring, if medically necessary, use consistently either CA 15-3 or CA 27.29, not both. CA 27.29 is equivalent to CA 15-3 in its usage in management of patients with breast cancer.
These services are not covered for the evaluation of patients with signs or symptoms suggestive of malignancy. The service may be ordered at times necessary to assess either the presence of recurrent disease or the patient’s response to treatment with subsequent treatment cycles.
To review all requirements of this policy, please see:
CMS NCD listing by Chapter
Covered ICD-10 Codes.
.... and many more.
|C44.1321||Sebaceous cell carcinoma skin/ r upper eyelid, inc canthus|
|C44.1322||Sebaceous cell carcinoma skin/ right low eyelid, inc canthus|
|C44.1391||Sebaceous cell carcinoma skin/ left upr eyelid, inc canthus|
|C44.1392||Sebaceous cell carcinoma skin/ left low eyelid, inc canthus|
|C50.011||Malignant neoplasm of nipple and areola, right female breast|
|C50.012||Malignant neoplasm of nipple and areola, left female breast|
|C50.019||Malignant neoplasm of nipple and areola, unsp female breast|
|C50.021||Malignant neoplasm of nipple and areola, right male breast|
|C50.022||Malignant neoplasm of nipple and areola, left male breast|
|C50.029||Malignant neoplasm of nipple and areola, unsp male breast|
Sorry, you need to login or register to view additional sections of this Medicare policy.
Click here for publications catalog.
The content and format of the following files and/or webpages are
copywritten and the property of Wheaton Partners, LLC - dba CodeMap®. All
recipients of these files agree not to distribute, reproduce and/or use the
information contained within, in any manner not expressly agreed upon by the
user and Wheaton Partners, LLC - dba CodeMap®.
All code-pairs and Medicare coverage information are compiled directly from Center for Medicare and
Medicaid Services (CMS) and Medicare Contractor coverage policies. CodeMap®
has made every reasonable effort to ensure the accuracy of the information
contained. However, the ultimate responsibility for correct
coding and claims submission lies with the provider of services. Both CMS and
Medicare contractor coverage policy information may change at any time.
CodeMap® makes no representation, warranty, or guarantee that this compilation
of coverage policy information is error-free or that the use of this information
will result in Medicare coverage and subsequent payment of claims. Final
coverage and payment of claims are subject to many factors exclusively
controlled by CMS and its contractors.